Matinas BioPharma Holdings, Inc. (MTNB) is a publicly traded Healthcare sector company. As of May 21, 2026, MTNB trades at $0.59 with a market cap of $3.46M and a P/E ratio of -0.30. MTNB moved +14.52% today. Year to date, MTNB is -0.64%; over the trailing twelve months it is -16.08%. Its 52-week range spans $0.47 to $4.25. Rallies surfaces MTNB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Matinas BioPharma Holdings, Inc. (MTNB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MTNB moved +14.52% today.
| Metric | Value |
|---|---|
| Price | $0.59 |
| Market Cap | $3.46M |
| P/E Ratio | -0.30 |
| EPS | $-2.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.25 |
| 52-Week Low | $0.47 |
| Volume | 312.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.35M |
| Gross Margin | 0.00% |
MTNB analyst coverage data. Average price target: $0.00.